Europe PMC
open access
Interferon-induced protein 35 (IFI35) is associated with COVID-19 severity and clinical outcomes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients#156278
- Autoantibodies against type I interferons in patients with zoonotic H7N9 influenza: an observational case–control study#1106660
- Data for: Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1#1099903
- The ISG Atlas: a loss-of-function analysis characterizes antiviral properties of interferon stimulated genes.#170582
- Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally#886367
Record · ID 5886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive